Hugh Taylor

No ORCID on file · 10 papers in corpus · active 2000-2026

Study types

  • article 4
  • review 3
  • letter 1
  • other 1
  • rct 1

Condition tags

  • endometriosis 8
  • infertility 2
review 2026
Changing the paradigm of endometriosis - from diagnosis to integrated long-term management: a joint society opinion paper
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2026.105642

Endometriosis is a chronic, systemic, oestrogen-dependent disease with major impacts on pain, fertility and quality of life. This Society of Endometriosis and Uterine Disorders and American Institute for Minimally Invasive Surgery opinion s…

rct 2025
Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.06.016

OBJECTIVE: To evaluate whether oral linzagolix administered once daily for up to 52 weeks (extension study) at a dose of 100 mg or 200 mg with or without hormonal add-back therapy (ABT) (1.0 mg estradiol; 0.5 mg norethisterone acetate) can …

other 2025
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials
Human reproduction open ·doi:10.1093/hropen/hoaf025

STUDY QUESTION: How important was the change in lumbar spine (L1-L4), femoral neck, and total hip bone mineral density (BMD) from post-treatment baseline values to 24 months after the end of treatment in PRIMROSE 1 and PRIMROSE 2 study part…

article 2022
Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial
BMJ open ·doi:10.1136/bmjopen-2021-052043

INTRODUCTION: Infertility is a common complication of endometriosis. While in vitro fertilisation-embryo transfer (IVF) successfully treats endometriosis-associated infertility, there is some evidence that pregnancy rates may be diminished …

article 2019
Evaluation of miR‑135a/b expression in endometriosis lesions
Biomedical reports ·doi:10.3892/br.2019.1237

The pathogenesis of endometriosis is not clear; however, microRNAs (miRNAs/miRs) are involved in the pathogenesis. miRNAs are short noncoding RNAs involved in post‑transcriptional regulation of gene expression by silencing the expression of…

review 2014
MicroRNA and gynecological reproductive diseases
Fertility and sterility ·doi:10.1016/j.fertnstert.2014.04.044
article 2011
Stem cells in endometrium and their role in the pathogenesis of endometriosis
·doi:10.1111/j.1749-6632.2011.05969.x/pdf
review 2008
Endometriosis and Tissue Factor
Annals of the New York Academy of Sciences ·doi:10.1196/annals.1434.008

Tissue factor (TF), is a cellular receptor that binds the ligand factor VII/VIIa to initiate the blood coagulation cascade. In addition to its role as the initiator of the hemostatic cascade, TF is known to be involved in angiogenesis via a…

article 2006
HOXA10 expression in ectopic endometrial tissue
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.10.072
letter 2000
Letter to the editor
·doi:10.1016/s0015-0282(00)01609-5